JP2021529159A5 - - Google Patents

Info

Publication number
JP2021529159A5
JP2021529159A5 JP2020570065A JP2020570065A JP2021529159A5 JP 2021529159 A5 JP2021529159 A5 JP 2021529159A5 JP 2020570065 A JP2020570065 A JP 2020570065A JP 2020570065 A JP2020570065 A JP 2020570065A JP 2021529159 A5 JP2021529159 A5 JP 2021529159A5
Authority
JP
Japan
Prior art keywords
alkyl
haloalkyl
pharmaceutically acceptable
acceptable salt
alkoxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020570065A
Other languages
English (en)
Japanese (ja)
Other versions
JP7328260B2 (ja
JP2021529159A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/055121 external-priority patent/WO2019244047A1/en
Publication of JP2021529159A publication Critical patent/JP2021529159A/ja
Publication of JP2021529159A5 publication Critical patent/JP2021529159A5/ja
Application granted granted Critical
Publication of JP7328260B2 publication Critical patent/JP7328260B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020570065A 2018-06-19 2019-06-18 Ｎ－置換テトラヒドロチエノピリジン誘導体及びその使用 Active JP7328260B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862687068P 2018-06-19 2018-06-19
US62/687,068 2018-06-19
PCT/IB2019/055121 WO2019244047A1 (en) 2018-06-19 2019-06-18 N-substituted tetrahydrothienopyridine derivatives and uses thereof

Publications (3)

Publication Number Publication Date
JP2021529159A JP2021529159A (ja) 2021-10-28
JP2021529159A5 true JP2021529159A5 (enExample) 2022-07-04
JP7328260B2 JP7328260B2 (ja) 2023-08-16

Family

ID=67841114

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020570065A Active JP7328260B2 (ja) 2018-06-19 2019-06-18 Ｎ－置換テトラヒドロチエノピリジン誘導体及びその使用

Country Status (24)

Country Link
US (3) US12012417B2 (enExample)
EP (2) EP4169925B1 (enExample)
JP (1) JP7328260B2 (enExample)
KR (1) KR102835904B1 (enExample)
CN (1) CN112313237A (enExample)
AU (1) AU2019291488B2 (enExample)
BR (1) BR112020025696A2 (enExample)
CA (1) CA3100957A1 (enExample)
CL (1) CL2020003248A1 (enExample)
CR (1) CR20200618A (enExample)
CU (1) CU20200100A7 (enExample)
EA (1) EA202190046A1 (enExample)
EC (1) ECSP20080995A (enExample)
ES (2) ES3062606T3 (enExample)
IL (1) IL279441B2 (enExample)
JO (1) JOP20200326A1 (enExample)
MA (1) MA52976A (enExample)
MX (1) MX2020013852A (enExample)
MY (1) MY201990A (enExample)
PE (1) PE20210097A1 (enExample)
PH (1) PH12020552185A1 (enExample)
SA (1) SA520420809B1 (enExample)
SG (1) SG11202012625PA (enExample)
WO (1) WO2019244047A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110945002B (zh) * 2017-08-01 2021-12-24 正大天晴药业集团股份有限公司 作为RORγ抑制剂的双环化合物
AU2019291488B2 (en) 2018-06-19 2022-02-24 Novartis Ag N-substituted tetrahydrothienopyridine derivatives and uses thereof
USD1006154S1 (en) * 2023-06-27 2023-11-28 Qiongfang Mao Cable crossover attachment
WO2025238553A1 (en) 2024-05-14 2025-11-20 Novartis Ag Dosing regimens for n-(3-cyano-5-(cyclohexylmethyl)-6,6-dimethyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)-2-(4-sulfamoylphenyl)acetamide for use in treating or preventing a dengue virus disease or disorder
WO2025253267A1 (en) 2024-06-06 2025-12-11 Janssen Pharmaceuticals, Inc. Combination of mosnodenvir and close analogs with nitd-688 for use in the treatment and prevention of dengue disease

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807A (en) 1848-09-26 Brake fob cabs
US4656A (en) 1846-07-24 Improvement in potato-plows
US6344A (en) 1849-04-17 Driving-bobbin
US54472A (en) 1866-05-01 Improved blacking-brush
US498178A (en) 1893-05-23 William valentine leonard
US8766A (en) 1852-02-24 Appabatus for lightening vessels
US5807876A (en) 1996-04-23 1998-09-15 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme
US6054472A (en) 1996-04-23 2000-04-25 Vertex Pharmaceuticals, Incorporated Inhibitors of IMPDH enzyme
HUP0004421A3 (en) 1996-04-23 2002-10-28 Vertex Pharmaceuticals Inc Cam Urea derivatives and pharmaceutical compositions containing them, use thereof for the treatment of deseases mediated by impdh enzyme
EP0966465B1 (en) 1997-03-14 2003-07-09 Vertex Pharmaceuticals Incorporated Inhibitors of impdh enzyme
AP1498A (en) 1999-03-19 2005-11-21 Vertex Pharma Inhibitors of impdh enzyme.
GB0114185D0 (en) 2001-06-12 2001-08-01 Protherics Molecular Design Lt Compounds
CN1288974C (zh) 2001-05-21 2006-12-13 孟山都技术公司 含有醚胺表面活性剂的农药浓缩物
US20030232994A1 (en) 2001-10-04 2003-12-18 Shao-Po Lu Bicyclic thiophene derivatives and combinatorial libraries thereof
CA2498399A1 (en) 2002-09-12 2004-03-25 Merck & Co., Inc. Method of treating diabetes and related conditions
US7138529B2 (en) * 2003-04-16 2006-11-21 Hoffmann-La Roche Inc. Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
GB0324653D0 (en) 2003-10-22 2003-11-26 Syngenta Participations Ag Fungicides
DK1753512T3 (da) 2004-05-28 2008-11-17 4Sc Ag Tetrahydropyridothiophener
AU2005272646A1 (en) 2004-08-12 2006-02-23 Wyeth Combination therapy for diabetes, obesity, and cardiovascular diseases using GDF-8 inhibitors
AU2006212224A1 (en) 2005-02-09 2006-08-17 4Sc Ag Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
AU2006212179A1 (en) 2005-02-11 2006-08-17 4Sc Ag Tetrahydropyridothiophenes as antripoliferative agents for the treatment of cancer
WO2006119646A1 (en) 2005-05-13 2006-11-16 Virochem Pharma Inc. Compounds and methods for the treatment or prevention of flavivirus infections
CA2609003A1 (en) 2005-05-25 2006-11-30 Nycomed Gmbh Tetrahydropyridothiophenes for use in the treatment of cancer
EP1893618A2 (en) 2005-05-25 2008-03-05 Nycomed GmbH Tetrahydropyridothiophenes for use in the treatment of cancer
US7932391B2 (en) 2005-09-08 2011-04-26 Zhejiang Hauhai Pharmaceutical Co., Ltd. Method for the preparation of clopidogrel and its analogues of methyl-tetrahydrothieno[3,2-C]pyridine acetate
WO2008020045A1 (en) 2006-08-16 2008-02-21 4Sc Ag Tetrahydrobenzothiophene derivatives
JP2010500395A (ja) 2006-08-16 2010-01-07 ４エスツェー アクチェンゲゼルシャフト 癌治療のためのテトラヒドロピリドチオフェン誘導体
AU2007325315A1 (en) 2006-11-28 2008-06-05 Kalypsys Inc Heterocyclic modulators of TGR5
WO2009086303A2 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
CN104856991A (zh) * 2009-02-27 2015-08-26 西佳技术公司 用于治疗和预防登革热病毒感染的噻吩并吡啶衍生物
US20130129677A1 (en) * 2009-02-27 2013-05-23 Siga Technologies, Inc. Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections
JP5701655B2 (ja) * 2011-03-29 2015-04-15 奈良県 植物精油中のトロポロン類及び／又はフェノール類の金属錯体化方法
JP2014528412A (ja) 2011-09-30 2014-10-27 キネタ・インコーポレイテツド 抗ウイルス化合物
CA3030582A1 (en) 2015-07-22 2017-01-26 The Royal Institution For The Advancement Of Learning/Mcgill University Compounds and uses thereof in the treatment of cancers and other medical conditions
CN108689987A (zh) 2017-04-05 2018-10-23 浙江海正药业股份有限公司 一种磺胺类衍生物及其制备方法和用途
UA125970C2 (uk) 2017-05-22 2022-07-20 Янссен Фармасьютікалз, Інк. Заміщені похідні індоліну як інгібітори реплікації вірусів денге
CN110945002B (zh) 2017-08-01 2021-12-24 正大天晴药业集团股份有限公司 作为RORγ抑制剂的双环化合物
CN108191885B (zh) 2018-01-29 2020-08-04 华东师范大学 一类哌啶并噻吩类小分子有机化合物及其应用
AU2019291488B2 (en) 2018-06-19 2022-02-24 Novartis Ag N-substituted tetrahydrothienopyridine derivatives and uses thereof

Similar Documents

Publication Publication Date Title
JP2021529159A5 (enExample)
JP2024520481A5 (enExample)
JP2021088610A5 (enExample)
RU2002131941A (ru) 3-азот-6,7-дикислородсодержащие стероиды и их применение
JP2023531524A5 (enExample)
JP2021513967A5 (enExample)
KR930702371A (ko) 뉴클레오시드 유도체
JPWO2022158528A5 (enExample)
JP2010539241A5 (enExample)
RU2006134020A (ru) Конденсированные производные пиразола
RU2009102252A (ru) Хиноксалинилмакроциклические ингибиторы серинпротеазы вируса гепатита с
RU2003110577A (ru) Гетероциклические соединения, связывающиеся с хемокиновыми рецепторами
JP2007505138A5 (enExample)
PE20090630A1 (es) Derivados de indol 2-carboxi sustituidos y metodos para su utilizacion
IL217228A (en) Compounds of Type 2'-Deoxy-2'-Fluoro-2'-c-Methyluridine Nucleoside Phosphoramide Compounds
JP2014503516A5 (enExample)
CN116751164A (zh) 蛋白酶抑制剂、其制备和用途
JP2007533740A5 (enExample)
RU2006125377A (ru) Гетероциклические ингибиторы аспартилпротеазы
JP2011521903A5 (enExample)
RU2008108024A (ru) Ингибиторы серинпротеазы
JP2023518411A5 (enExample)
JP2020507589A5 (enExample)
RU2014113539A (ru) Тетрациклические гетероциклические соединения и способы их применения для лечения вирусных заболеваний
AR116474A1 (es) DERIVADOS DEL ÁCIDO 6,7-DIHIDRO-2H-BENZOFURO[2,3-a]QUINOLIZIN-3-CARBOXÍLICO COMO AGENTES ANTIVIRALES PARA EL TRATAMIENTO O PREVENCIÓN DE UNA INFECCIÓN POR HBV